TNX-1900

Drug identity checked against registry records

Also recorded as intranasal oxytocin

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Study to Evaluate the Efficacy and Safety of TNX-1900 in Patients With Chronic MigraineNCT05679908Tonix Pharmaceuticals, Inc.Phase 2Completed2023-10-08Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.